Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter of 2025, with several funds increasing holdings by over 100% according to SEC filings.
Astra AB
CompanyCompany Profile
Astra AB was a Swedish pharmaceutical company headquartered in Sodertalje that was founded in 1913. It merged with the British Zeneca Group in 1999 to form AstraZeneca.
- Headquarters
- Sodertalje, Sweden
- Founded
- 1913
Related News
Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their stakes in AstraZeneca during the third quarter of 2025, with the stock trading near its 52-week high and maintaining a "Moderate Buy" rating from analysts.
Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter, with AMG National Trust Bank, Cibc World Market Inc., and Advisors Asset Management Inc. increasing holdings by approximately 20%.
Institutional Investors Adjust AstraZeneca Holdings in Q3
Multiple institutional investors modified their positions in AstraZeneca during the third quarter, with new stakes and adjustments reported in SEC filings. The company announced a dividend of $1.595 per share payable March 23rd.